Straumann Holding AG

Straumann Holding AG

0QMV · LSE

107.36GBP+0.37 (+0.35%)

Price History

Full chart

Market Stats

Previous Close107.00
Open107.55
Day Range107.00 – 107.75
52-Week Range73.23 – 122.32
Volume7.15K
Market Cap1.98B
P/E (TTM)0.50
Forward P/E0.00
EPS2.48
Dividend Yield0.01%
Beta1.37
50-Day Avg134.00
200-Day Avg130.35

About

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Company Details

  • CEOMr. Guillaume Daniellot
  • Employees11.58K
  • HeadquartersPeter Merian-Weg 12, Basel, Switzerland, 4002, UK
  • Websitehttps://www.straumann.com

Leadership

  • Mr. Guillaume DaniellotCEO, Interim Head of Dental Service Organizations & Member of Executive Management Board · b. 1970
  • Ms. Isabelle WegeCFO & Member of Executive Management Board · b. 1985
  • Mr. Kok-Kien LohRegional Head Asia Pacific & Member of the Executive Management Board · b. 1967
  • Mr. Holger HadererRegional Head of Europe, Middle East & Africa and Member of Executive Management Board · b. 1969
  • Mr. Sébastien RocheChief Operations & Supply Chain Officer and Member of Executive Management Board · b. 1972
  • Mr. Florian KirschHead of Integrated Dental Technologies & Member of Management Board · b. 1982
  • Mr. Andreas UtzHead of Implantology Business Unit (IBU) and Member of Executive Management Board · b. 1976
  • Ms. Sara DalmassoHead of the Dental Service Organization (DSO) and Member of Executive Management Board · b. 1977
  • Mr. Thomas FrieseChief Technology & Information Officer and Member of Executive Management Board · b. 1975
  • Mr. Alexei CostaExecutive VP of Latin America, President Neodent & Member of Executive Management Board · b. 1978

Financials

Income Statement

Currency: GBP2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue274.90M343.87M420.30M509.55M599.20M713.65M778.71M736.36M737.65M693.58M686.25M679.92M710.27M798.60M917.52M1.11B1.36B1.60B1.43B2.02B2.32B2.41B2.50B2.61B
Growth (%)-+25.09%+22.23%+21.24%+17.59%+19.10%+9.12%-5.44%+0.17%-5.97%-1.06%-0.92%+4.46%+12.44%+14.89%+21.21%+22.61%+17.06%-10.67%+41.80%+14.78%+3.92%+3.82%+4.05%
Cost of Revenue54.36M69.08M45.42M52.11M58.26M131.38M147.21M149.53M150.63M165.04M154.73M144.01M151.62M170.66M198.99M271.64M335.31M395.75M399.54M492.64M619.50M623.41M720.52M835.26M
Gross Profit220.53M274.79M374.87M457.44M540.94M582.27M631.50M586.83M587.02M528.54M531.52M535.91M558.65M627.94M718.53M840.46M1.03B1.20B1.03B1.53B1.70B1.79B1.78B1.77B
Gross Margin80.22%79.91%89.19%89.77%90.28%81.59%81.10%79.69%79.58%76.20%77.45%78.82%78.65%78.63%78.31%75.57%75.41%75.21%71.98%75.63%73.31%74.15%71.22%67.94%
Operating Expense145.77M175.56M247.91M301.50M365.62M380.76M591.10M421.50M422.71M448.62M470.51M420.99M410.84M442.85M491.70M557.54M676.89M800.14M710.02M992.76M1.17B1.38B1.18B1.23B
Operating Income74.76M99.23M126.97M155.94M175.32M201.51M40.41M165.34M164.31M79.92M61.01M114.92M147.81M185.09M226.83M282.92M351.36M400.33M316.30M536.51M530.49M410.97M601.00M537.93M
Operating Margin27.20%28.86%30.21%30.60%29.26%28.24%5.19%22.45%22.27%11.52%8.89%16.90%20.81%23.18%24.72%25.44%25.77%25.08%22.18%26.53%22.86%17.04%24.00%20.65%
EBITDA93.36M121.76M155.20M184.15M214.00M242.66M135.38M251.57M208.04M114.94M93.57M140.43M175.69M218.05M258.86M323.18M403.73M479.20M230.45M591.48M685.37M685.07M726.15M696.07M
EBITDA Margin33.96%35.41%36.93%36.14%35.71%34.00%17.39%34.16%28.20%16.57%13.63%20.65%24.74%27.30%28.21%29.06%29.61%30.02%16.16%29.25%29.53%28.40%29.00%26.72%
Net Income55.97M80.30M99.95M127.86M141.72M175.87M8.16M146.37M131.08M70.95M36.44M101.20M157.82M70.68M229.60M272.92M272.77M306.47M91.28M396.08M434.79M246.07M388.32M355.92M
Net Income Margin20.36%23.35%23.78%25.09%23.65%24.64%1.05%19.88%17.77%10.23%5.31%14.88%22.22%8.85%25.02%24.54%20.00%19.20%6.40%19.59%18.73%10.20%15.51%13.66%
R&D31.35M34.75M3.81M4.87M4.98M31.23M37.11M39.11M40.47M39.02M48.67M1.13M---2.02M6.15M6.20M128.56M96.00M104.60M111.10M115.90M-
R&D as % of Total Revenue11.41%10.11%0.91%0.96%0.83%4.38%4.77%5.31%5.49%5.63%7.09%0.17%---0.18%0.45%0.39%9.02%4.75%4.51%4.61%4.63%-
Interest Expense310.00K-2.06M543.00K716.00K6.57M48.01M25.38M32.67M31.57M728.00K3.70M4.34M4.46M4.28M6.02M8.73M17.62M15.49M16.94M17.19M14.97M21.66M14.55M
Interest Expense % of Total Revenue0.11%-0.49%0.11%0.12%0.92%6.17%3.45%4.43%4.55%0.11%0.54%0.61%0.56%0.47%0.54%0.64%1.10%1.09%0.84%0.74%0.62%0.86%0.56%

Balance Sheet

Currency: GBP2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets251.04M351.79M404.53M536.28M646.95M946.48M728.25M802.94M853.89M811.26M772.61M1.02B1.16B1.05B1.09B1.70B1.86B2.46B2.62B3.05B3.45B3.40B3.62B3.82B
Total Liabilities61.06M95.82M92.91M116.29M143.37M322.99M190.59M167.52M158.26M140.15M141.40M388.36M423.94M441.33M456.24M619.92M660.25M1.09B1.41B1.55B1.60B1.56B1.58B1.65B
Total Equity188.91M254.09M309.50M418.48M503.57M619.68M537.66M635.42M695.63M671.12M631.21M631.38M736.84M604.97M633.68M1.08B1.20B1.36B1.20B1.50B1.85B1.84B2.04B2.16B
Cash70.30M103.36M107.11M94.19M171.81M190.19M147.90M261.57M349.60M377.05M140.50M383.80M459.42M318.30M164.02M281.82M278.67M260.21M632.20M880.42M696.10M410.31M375.49M475.43M
Total Debt14.20M29.20M---137.42M50.00M---47.00K199.34M199.44M199.57M199.79M201.76M201.91M455.50M731.66M706.57M705.20M412.35M413.89M503.04M
Net Debt-56.10M-74.16M-107.11M-94.19M-171.81M-52.77M-97.90M-261.57M-349.60M-377.05M-140.46M-184.45M-259.98M-118.73M35.76M-80.05M-76.76M195.29M99.45M-173.85M9.10M2.04M38.40M27.61M

Cash Flow

Currency: CHF2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow69.66M118.03M144.20M144.49M174.58M223.15M198.76M245.14M175.84M140.22M114.56M151.49M146.16M185.60M184.74M217.29M277.10M378.48M376.59M560.30M415.15M503.95M483.39M505.42M
Investing Cash Flow-22.80M-84.84M-64.81M-121.07M-43.33M-245.48M-89.82M-31.13M-22.40M-25.62M-285.55M-62.59M-25.93M-48.10M-83.39M-292.85M-199.33M-237.15M-144.82M-175.22M-434.66M-349.33M-352.62M-275.35M
Financing Cash Flow-10.76M-414.00K-75.22M-36.85M-54.02M40.11M-135.66M-96.36M-56.14M-89.85M-63.49M155.65M-44.99M-274.67M-257.05M192.57M-77.56M-156.49M153.33M-131.24M-154.31M-424.40M-169.06M-105.95M
Capital Expenditure13.59M26.42M65.52M52.48M37.46M37.66M55.38M31.35M22.14M19.42M19.43M10.91M16.88M32.06M39.17M66.55M92.92M134.60M70.84M105.13M161.60M189.43M167.77M175.63M
Free Cash Flow56.07M91.61M78.68M92.01M137.13M185.49M143.38M213.79M153.70M120.79M95.13M140.58M129.28M153.53M145.57M150.74M184.18M243.88M305.75M455.18M253.55M316.61M315.62M329.78M
Dividends Paid9.29M17.43M48.08M31.14M39.04M46.73M58.41M58.41M58.69M58.76M58.03M57.85M58.26M58.56M63.15M65.14M75.12M83.13M91.23M91.38M107.43M127.44M135.43M151.34M
FCF to OCF80.49%77.62%54.56%63.68%78.55%83.12%72.14%87.21%87.41%86.15%83.04%92.80%88.45%82.72%78.80%69.37%66.47%64.44%81.19%81.24%61.07%62.83%65.29%65.25%
Dividend Paid to FCF16.56%19.03%61.10%33.84%28.47%25.19%40.74%27.32%38.18%48.65%61.00%41.15%45.07%38.14%43.38%43.21%40.79%34.08%29.84%20.08%42.37%40.25%42.91%45.89%

Earnings

Report DateOct 28, 2026
EPS Estimate-
EPS Actual-
Surprise-
TimingAfter-hours

Key Statistics & Ratios

Market Cap1.98B
Enterprise Value14.62B
Trailing P/E0.50
Forward P/E0.00
Price / Sales0.76
Price / Book0.00
EPS2.48
Book Value14.35
Revenue (TTM)2.64B
Gross Profit (TTM)1.83B
EBITDA750.60M
Profit Margin14.00%
Operating Margin25.14%
Return on Equity17.05%
Return on Assets10.99%
Shares Outstanding15.82M
Shares Float107.62M
Beta1.37
Dividend Yield0.01%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20261×
0.01Apr 21, 2026
20251×
0.01Apr 14, 2025
20241×
0.00Apr 16, 2024
20231×
0.01Apr 11, 2023
20221×
0.01Apr 7, 2022
20211×
0.01Apr 13, 2021
20201×
0.01Apr 9, 2020
20191×
0.01Apr 9, 2019
20181×
0.00Apr 10, 2018
20171×
0.00Apr 11, 2017
20161×
0.00Apr 12, 2016
20151×
0.00Apr 14, 2015

Stock Splits

  • Apr 20, 202210:1